BRAIN Biotech AG financial highlights

in € million 2020/21 2019/20 2018/19
Consolidated income statement data:
Revenue 38.4 38.2 38.6
Total operating performance 40.7 39.2 41.2
EBITDA –2.5 –3.9 –2.5
Adjusted EBITDA –2.1 –2.0 –2.1
Net loss for the reporting period –4.7 –9.0 –10.5
Consolidated balance sheet data:
Total equity 41.8 26.1 17.1
Equity ratio (in %) 53.8% 36.2% 25.8%
Total assets 77.7 72.2 66.1
Consolidated cash flow data:
Cash flows from operating activities –3.9 –4.8 –3.4
Cash flows from investing activities –2.2 –4.5 –6.7
Cash flows from financing activities 11.6 13.1 –0.3

Share this page